Hedge Fund - Biotechnology Value Fund / BVF Inc
Concert Pharmaceuticals Inc. (CNCE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $7.96 |
| 2 | 2022 - Q4 (2022-12-31) | $21,193,360 | 0.89% | 3,629,000 | $5.26 |
| 3 | 2022 - Q3 (2022-09-30) | $24,314,000 | 1% | 3,629,000 | $6.06 |
| 4 | 2022 - Q2 (2022-06-30) | $15,278,000 | 0.73% | 3,629,000 | $3.96 |
| 5 | 2022 - Q1 (2022-03-31) | $7,593,000 | 0.3% | 2,253,000 | $3.17 |
| 6 | 2021 - Q4 (2021-12-31) | $7,097,000 | 0.25% | 2,253,000 | $3.33 |
| 7 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $10.61 |
| 8 | 2019 - Q2 (2019-06-30) | $19,538,000 | 2.13% | 1,628,187 | $10.75 |
| 9 | 2019 - Q1 (2019-03-31) | $16,723,000 | 1.87% | 1,385,487 | $14.74 |
| 10 | 2018 - Q4 (2018-12-31) | $14,438,000 | 1.88% | 1,150,445 | $13.81 |
| 11 | 2018 - Q3 (2018-09-30) | $23,627,000 | 2.07% | 1,592,138 | $15.73 |
| 12 | 2018 - Q2 (2018-06-30) | $30,582,000 | 2.98% | 1,817,138 | $19.42 |
| 13 | 2018 - Q1 (2018-03-31) | $44,246,000 | 4.48% | 1,932,123 | $22.24 |
| 14 | 2017 - Q4 (2017-12-31) | $50,958,000 | 6.14% | 1,969,789 | $20.13 |
| 15 | 2017 - Q3 (2017-09-30) | $46,246,000 | 5.87% | 3,135,289 | $14.51 |
| 16 | 2017 - Q2 (2017-06-30) | $25,904,000 | 4.02% | 1,856,895 | $14.74 |
| 17 | 2017 - Q1 (2017-03-31) | $39,863,000 | 6.78% | 2,336,609 | $11.99 |
| 18 | 2016 - Q4 (2016-12-31) | $26,921,000 | 5.4% | 2,616,249 | $9.14 |
| 19 | 2016 - Q3 (2016-09-30) | $27,532,000 | 5.18% | 2,723,210 | $10.93 |
| 20 | 2016 - Q2 (2016-06-30) | $30,942,000 | 6.59% | 2,755,318 | $12.73 |
| 21 | 2016 - Q1 (2016-03-31) | $37,638,000 | 9.31% | 2,755,318 | $14.39 |
| 22 | 2015 - Q4 (2015-12-31) | $42,341,000 | 7.21% | 2,232,014 | $21.73 |
| 23 | 2015 - Q3 (2015-09-30) | $42,330,000 | 8.55% | 2,255,168 | $17.00 |
| 24 | 2015 - Q2 (2015-06-30) | $37,544,000 | 6.62% | 2,521,452 | $15.23 |
| 25 | 2015 - Q1 (2015-03-31) | $20,304,000 | 4.24% | 1,340,659 | $13.95 |
| 26 | 2014 - Q4 (2014-12-31) | $16,070,000 | 3.12% | 1,206,459 | $12.91 |
| 27 | 2014 - Q3 (2014-09-30) | $15,213,000 | 3.15% | 1,206,459 | $9.70 |
The displayed share prices are average quarterly stock market prices.